Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring
Elypta has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in March 2023.
Elypta's investors include Norrsken VC, Nina Capital, Sciety, Chalmers Ventures AB, EISMEA.
Elypta is headquartered in Stockholm, Sweden.
Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring
Elypta is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elypta — Funding & Investors." VCBacked, March 28, 2023, https://www.vcbacked.co/company/elypta. Accessed August 15, 2026.
VCBacked. (2023). Elypta — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/elypta
{{cite web |title=Elypta — Funding & Investors |url=https://www.vcbacked.co/company/elypta |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated